Clexane 40 Mg 2 Syringe

Clexane 40 Mg 2 Syringe

Description:

Clexane 40 mg is a prescription anticoagulant medicine containing enoxaparin sodium, a low molecular weight heparin (LMWH). It is supplied as prefilled syringes for subcutaneous injection and is used to prevent and treat blood clots (thromboembolic disorders) in adults. Clexane helps reduce the risk of deep vein thrombosis (DVT), pulmonary embolism (PE), and clot formation in situations such as surgery, prolonged immobilization, and certain medical conditions that increase clotting risk. This product is intended for use under medical supervision only.

Indications:

• Prevention of deep vein thrombosis (DVT), especially in patients undergoing orthopedic or general surgery, or in those who are bedridden or immobilized due to acute illness.
• Prevention of pulmonary embolism (PE) secondary to DVT.
• Treatment of established deep vein thrombosis with or without pulmonary embolism (dose and regimen as prescribed by the physician).
• Prevention of thromboembolic complications in patients with acute medical conditions at risk of clot formation (e.g., heart failure, severe infection, respiratory failure) as directed by the doctor.
• Prevention of clot formation in certain cardiovascular conditions (e.g., unstable angina, non–ST-elevation myocardial infarction) when prescribed as part of a treatment protocol.

Active Ingredients / Key Components:

• Enoxaparin sodium – 40 mg per prefilled syringe (low molecular weight heparin anticoagulant). The concentration in the reference product is 100 mg/ml; exact volume per 40 mg syringe is not specified in the provided information.
• Excipients: Other inactive ingredients (such as water for injections and stabilizers) are present but not specified in the provided information.

Dosage & Administration / How to Use:

• Use only as prescribed by a physician experienced in anticoagulant therapy.
• Typical prophylactic adult dose for DVT prevention is often 40 mg enoxaparin sodium once daily by subcutaneous injection; however, the exact dose, frequency, and duration must be determined by the treating doctor based on body weight, kidney function, indication, and overall risk profile.
• Administration route: subcutaneous injection only. Do not administer intramuscularly.
• Injection technique (general guidance – follow healthcare provider’s instructions):
  • Wash hands thoroughly before handling the syringe.
  • Choose an injection site in the fatty tissue of the abdomen (at least 5 cm away from the navel), alternating sides each time, or as instructed by your healthcare professional.
  • Clean the skin with an antiseptic swab and allow it to dry.
  • Pinch a fold of skin between thumb and forefinger and insert the needle vertically (90°) into the skin fold.
  • Inject the full contents of the prefilled syringe slowly as directed.
  • Do not rub the injection site after administration to reduce the risk of bruising.
• Do not adjust the dose or stop treatment without consulting your doctor, as sudden discontinuation may increase the risk of clot formation.
• In patients with kidney impairment, low body weight, obesity, or increased bleeding risk, dosing must be individualized by the physician.

Clinical Benefits:

• Helps prevent formation of dangerous blood clots (deep vein thrombosis and pulmonary embolism) in high‑risk patients.
• Provides predictable anticoagulant effect with low molecular weight heparin, reducing the need for frequent laboratory monitoring compared with some other anticoagulants (as per physician’s judgment).
• Supports safer recovery after surgery or during prolonged immobilization by lowering the risk of thromboembolic complications.
• Prefilled syringe format ensures accurate dosing and convenient administration under medical guidance.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to enoxaparin sodium, heparin, other low molecular weight heparins, or any component of the product.
• Contraindicated in patients with uncontrolled active bleeding or conditions with a high risk of major bleeding.
• Contraindicated in patients with a history of heparin-induced thrombocytopenia (HIT) unless specifically managed by a specialist.
• Use with extreme caution in patients with severe kidney impairment, liver disease, bleeding disorders, recent hemorrhagic stroke, uncontrolled hypertension, gastrointestinal ulcers, recent surgery to the brain, spine, or eyes, or in those receiving other medicines that affect blood clotting (e.g., warfarin, direct oral anticoagulants, antiplatelet agents, NSAIDs).
• This product is derived from pork sources; do not use in patients with allergy to pork products or in those who avoid pork for religious or other reasons, unless approved by their physician.
• Regular monitoring of platelet counts, kidney function, and signs of bleeding may be required as directed by the doctor.
• Consult your doctor before use if pregnant or planning pregnancy. Enoxaparin may be used in pregnancy only under strict medical supervision when benefits outweigh risks.
• If breastfeeding, consult your healthcare provider before use.
• Inform your doctor and dentist that you are using Clexane before any surgery, dental procedure, or invasive intervention.
• Do not share syringes with others. For single‑patient use only.
• Consult your doctor before use if you are taking any other medications, including over‑the‑counter medicines, herbal products, or supplements that may affect bleeding risk.
• Not intended to diagnose, treat, cure, or prevent any disease on its own; it must be used as part of a treatment plan prescribed by a healthcare professional.
• Keep out of reach of children.

Side Effects:

• Common side effects: bruising, pain, redness, or mild irritation at the injection site; mild bleeding (e.g., from gums or nose), small skin hematomas.
• Less common but serious side effects: severe bleeding (unusual bruising, black or bloody stools, blood in urine, coughing or vomiting blood), sudden severe headache, dizziness, weakness, or fainting; signs of allergic reaction such as rash, itching, swelling of face or throat, or difficulty breathing.
• Heparin‑induced thrombocytopenia (HIT): a rare but serious drop in platelet count that can increase the risk of clotting. Symptoms may include new or worsening clots, chest pain, shortness of breath, or leg swelling. Immediate medical evaluation is required.
• Spinal/epidural hematoma (in patients receiving spinal or epidural anesthesia or undergoing spinal puncture): may cause long‑term or permanent paralysis. Seek urgent medical help if you experience numbness, tingling, muscle weakness (especially in legs), or loss of bladder/bowel control.
• Stop using the product and seek immediate medical attention if you notice any signs of severe bleeding, allergic reaction, or other worrying symptoms.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and heat. Do not freeze. Keep the syringes in their original packaging until use to protect from light and contamination. Keep container tightly closed and out of reach of children. Do not use after the expiry date printed on the pack. Do not use if the solution is discolored, contains particles, or if the syringe is damaged.

Specifications:

• Product type: Prescription anticoagulant medicine (low molecular weight heparin).
• Active ingredient: enoxaparin sodium 40 mg per prefilled syringe.
• Form: prefilled syringes for subcutaneous injection.
• Pack size: 2 prefilled syringes.
• Intended users: adults, and specific patients as determined by a physician.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.